CohBar Antifibrotic Peptide in Combination with Nintedanib Shows Enhanced Effects in an Idiopathic Pulmonary Fibrosis Model Oct 26, 2020
CohBar’s CEO to Participate on the Emerging Companies Panel at the Targeting Metabesity Conference Oct 8, 2020